Literature DB >> 15651498

[The practice guideline: 'Treatment of tobacco dependence'].

C van Weel1, J W W Coebergh, T Drenthen, G M Schippers, P I van Spiegel, P D Anderson, F A van Bladeren, H van Veenendaal.   

Abstract

The interdisciplinary guideline 'Treatment of tobacco dependence' discusses the approach to smoking patients. The point of departure is the concept that smoking is an addiction and that its treatment should be based on this fact. The effectiveness of treatment depends on the patient's motivation to stop smoking and on the intensity of the intervention. Pharmacotherapy may be of added value here, particularly for persistent smokers. The guideline aims at reaching as many smoking patients as possible, regardless of whether there is a relationship between their symptoms or ill health and smoking. Practitioners should ask about smoking habits regularly and smokers should be advised at least once to stop. Further treatment and guidance aims in particular to increase the motivation to quit and at those who are prepared to stop on the basis of the stages-of-change model. More intensive possibilities for treatment, by both general practitioners and specialists, are needed for persistent smokers. Such facilities are hardly available at all in The Netherlands at present, but will have to be developed to make the cost-effective treatment of tobacco addiction possible on a large scale.

Entities:  

Mesh:

Year:  2005        PMID: 15651498

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  2 in total

1.  Effectiveness of a telephone delivered and a face-to-face delivered counseling intervention for smoking cessation in patients with coronary heart disease: a 6-month follow-up.

Authors:  Nadine Berndt; Catherine Bolman; Erika Sivarajan Froelicher; Aart Mudde; Math Candel; Hein de Vries; Lilian Lechner
Journal:  J Behav Med       Date:  2013-06-13

2.  Smoking cessation quitlines in Europe: matching services to callers' characteristics.

Authors:  Marc C Willemsen; Regina M van der Meer; Gerard M Schippers
Journal:  BMC Public Health       Date:  2010-12-18       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.